SCs and paracrine factors | Type of study | N | Type of alopecia | Mechanism | Effect | Authors | Refs. |
---|---|---|---|---|---|---|---|
hUCB-MSCs | In-vitro | 55 | – | VEGF-related β-catenin and p-GSK-3β [SER9] signaling pathway | ↑ Viability in DPCs ↑ hair density, thickness, and growth rate | Oh et al | [57] |
ASCs | In-vitro (Human DPCs) | – | – | – | Telogen-to-anagen transition Upregulation growth factors | Choi et al | [58] |
MSCs | In-vitro | – | Alopecia Areata | Wnt/ β-Catenin pathway Phosphorylation of JAK1 to 3, STAT1, and STAT3 | ↑ Viability of Human Outer root sheath cells (h-ORSCs) | Lee et al | [59] |
Exosomes from ADSCs | In-vitro | – | – | ↑ Expression of ALP, versican and α-SMA proteins | ↑ DPC proliferation | Nilforoushzadeh et al | [60] |
MSC-EVs | In-vivo (C57BL/6 mice) Invitro | 17 mice |  | ↑ Bcl-2, phosphorylated Akt and ERK ↑ telogen to anagen ↑expression of wnt3a, wnt5a and versican | ↑ DP cell proliferation | Rajendran et al | [61] |
ADSC-Exos | In vitro In vivo (C57BL/6 hair-depilated mouse) | 15 mice | Immune-Mediated Alopecia | regulating miR-22 Wnt/β-catenin signaling pathway TNF-α signaling pathway | Hair regrowth | Li et al | [51] |
hUCB-MSCs | In-vivo (C3H/HeJ mice) Invitro | Â | Â | Paracrine mechanism | Hair growth | Bak et al | [37] |
HF-MSCs | In vitro In vivo: (C3H/HeJ AA) |  | AA |  | ↓ Hair loss ↓Inflammation around HF | Deng et al | [62] |
NSC (TGF-b) | In-vivo (Animal C57BL/6 mice) | 20 |  |  | ↑ Keratinocytes and DPCs ↑ Hair shaft length and growth rate | Hwang et al | [63] |
ADSC | In-vivo (Animal model- C3H/NeH mice) | 21 |  |  | ↑ Anagen phase ↑ Hair regeneration, ↑proliferation of hDPCs | Park et al | [64] |
ADSCs | In-vivo (Animal model- C57BL/6 J mice) | 37 |  | Wnt/β-catenin pathway | ↑Hair growth ↑Telogen-to-anagen transition ↑Proliferation, migration and cell cycle progression | Li et al | [65] |
ADSCs | In-vivo (Animal model- C57BL/6 J mice) | 37 |  | Wnt/β-catenin pathway | ↑Hair growth ↑Telogen-to-anagen transition ↑Proliferation, migration, and cell cycle progression | Li et al | [65] |
dental pulp stem cells | Invivo (C3H/HeN female mice) | 20 |  |  | ↑ Anagen-staged hair follicles ↓ Number of telogen staged hair follicles | Gunawardena et al | [66] |
hESCs | In vivo (NUDE mice) | Â | Â | Â | Hair growth | Gnedeva et al | [67] |
iPSCs | In-vivo (nude mice) | – | – | – | Unlimited source of folliculogenic cells | Pinto and Terskikh | [68] |
ADSC | In-vivo (Human) | 1000 | – | – | ↑ Total number hair shafts | Fukuoka et al | [69] |
ADSCs | In-vivo (Human) | 22 | alopecia | – | ↑ Hair number | Fukuoka and Suga | [70] |
HF-MSCs (FGF-7) | In-vivo (Human) | 21 | AGA | ERK activation Wnt signaling pathway | ↑ Hair density ↑ Anagen phase | Gentile et al | [71] |
HFSCs | In-vivo (Human) | 11 | AGA | – | ↑Hair follicle number and hair density | Gentile et al | [72] |
MSCs | In vivo (Human) | 4 | Alopecia Areata | – | Hair regrowth | Czarnecka et al | [73] |
autologous SCs | In vivo (Human) | 40 | AA and AGA | – | Hair growth | Elmaadawi et al | [74] |
stem cell educator therapy | In vivo (Human) | 9 | AA | – | ↑ Hair growth and quality of life | Yanjia Li et al | [75] |